Connor, Clark & Lunn Investment Management »

Corvus Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $125k 71k 1.76
2023-09-30 $104k 71k 1.46
2023-06-30 $193k 84k 2.29
2020-06-30 $231k 85k 2.72
2020-03-31 $181k 86k 2.11
2019-12-31 $445k 82k 5.44
2019-09-30 $225k 75k 3.01
2019-06-30 $241k 64k 3.75
2019-03-31 $237k 59k 4.02
2018-12-31 $183k 50k 3.67
2018-09-30 $414k 48k 8.58
2018-06-30 $523k 48k 10.99
2018-03-31 $515k 45k 11.52
2017-12-31 $329k 32k 10.35
2017-09-30 $432k 27k 15.94
2017-06-30 $271k 22k 12.10